-
1
-
-
34250648482
-
Stress-related mucosal disease in the intensive care unit: an update on prophylaxis
-
Sessler J.M. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis. AACN Adv Crit Care 2007, 18(2):119-128.
-
(2007)
AACN Adv Crit Care
, vol.18
, Issue.2
, pp. 119-128
-
-
Sessler, J.M.1
-
2
-
-
18044396773
-
Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients
-
Stollman N., Metz D.C. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients. J Crit Care 2005, 20(1):35-45.
-
(2005)
J Crit Care
, vol.20
, Issue.1
, pp. 35-45
-
-
Stollman, N.1
Metz, D.C.2
-
3
-
-
18644377612
-
Contemporary strategies for the prevention of stress-related mucosal bleeding
-
Martindale R.G. Contemporary strategies for the prevention of stress-related mucosal bleeding. Am J Health Syst Pharm 2005, 62(10):S11-S17.
-
(2005)
Am J Health Syst Pharm
, vol.62
, Issue.10
-
-
Martindale, R.G.1
-
4
-
-
0028097917
-
Risk factors for gastrointestinal bleeding in critically ill patients
-
Cook D.J., Fuller H.D., Guyatt G.H., et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 1994, 330:377-381.
-
(1994)
N Engl J Med
, vol.330
, pp. 377-381
-
-
Cook, D.J.1
Fuller, H.D.2
Guyatt, G.H.3
-
5
-
-
33749176785
-
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients
-
Heidelbaugh J.J., Inadomi J.M. Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol 2006, 101(10):2200-2205.
-
(2006)
Am J Gastroenterol
, vol.101
, Issue.10
, pp. 2200-2205
-
-
Heidelbaugh, J.J.1
Inadomi, J.M.2
-
6
-
-
34347375966
-
Stress ulcer prophylaxis in hospitalized patients not in intensive care units
-
Grube R.R.A., Byron M.D. Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm 2007, 64(13):1396-1400.
-
(2007)
Am J Health Syst Pharm
, vol.64
, Issue.13
, pp. 1396-1400
-
-
Grube, R.R.A.1
Byron, M.D.2
-
7
-
-
61549124132
-
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome
-
Ho P.M., Maddox T.M., Wang L., et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009, 301(9):937-944.
-
(2009)
JAMA
, vol.301
, Issue.9
, pp. 937-944
-
-
Ho, P.M.1
Maddox, T.M.2
Wang, L.3
-
8
-
-
0023612057
-
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers
-
Driks M.R., Craven D.E., Celli B.R., et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 1987, 317(22):1376-1382.
-
(1987)
N Engl J Med
, vol.317
, Issue.22
, pp. 1376-1382
-
-
Driks, M.R.1
Craven, D.E.2
Celli, B.R.3
-
9
-
-
0034605783
-
Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials
-
Messori A., Trippoli S., Vaiani M., et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ 2000, 321(7269):1103-1106.
-
(2000)
BMJ
, vol.321
, Issue.7269
, pp. 1103-1106
-
-
Messori, A.1
Trippoli, S.2
Vaiani, M.3
-
10
-
-
77953289380
-
Drug combination linked to clostridium outbreaks
-
Elliot V.S. Drug combination linked to clostridium outbreaks. Am Med News 2004, 47(24):42.
-
(2004)
Am Med News
, vol.47
, Issue.24
, pp. 42
-
-
Elliot, V.S.1
-
11
-
-
0024232252
-
Haematological adverse effects of histamine H2-receptor antagonists
-
Aymard J.P., Aymard B., Netter P., et al. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol Adverse Drug Exp 1988, 3(6):430-448.
-
(1988)
Med Toxicol Adverse Drug Exp
, vol.3
, Issue.6
, pp. 430-448
-
-
Aymard, J.P.1
Aymard, B.2
Netter, P.3
-
12
-
-
34248363243
-
Stress-ulcer prophylaxis for general medical patients: a review of the evidence
-
Janicki T., Stewart S. Stress-ulcer prophylaxis for general medical patients: a review of the evidence. J Hosp Med 2007, 2(2):86-92.
-
(2007)
J Hosp Med
, vol.2
, Issue.2
, pp. 86-92
-
-
Janicki, T.1
Stewart, S.2
-
13
-
-
23244466254
-
Complications of critical illness: rational for prophylactic strategies
-
Patel G.P., Liberman J., Gurka D., et al. Complications of critical illness: rational for prophylactic strategies. Clin Pulm Med 2005, 12(4):258-268.
-
(2005)
Clin Pulm Med
, vol.12
, Issue.4
, pp. 258-268
-
-
Patel, G.P.1
Liberman, J.2
Gurka, D.3
-
14
-
-
5644251578
-
Prevention of stress ulceration: current trends in critical care
-
Daley R.J., Rebuck J.A., Welage L.S., et al. Prevention of stress ulceration: current trends in critical care. Crit Care Med 2004, 32(10):2008-2013.
-
(2004)
Crit Care Med
, vol.32
, Issue.10
, pp. 2008-2013
-
-
Daley, R.J.1
Rebuck, J.A.2
Welage, L.S.3
-
15
-
-
0027142483
-
Simulation study of confounder-selection strategies
-
Moldanado G., Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol 1993, 138:923-936.
-
(1993)
Am J Epidemiol
, vol.138
, pp. 923-936
-
-
Moldanado, G.1
Greenland, S.2
-
16
-
-
33947517877
-
Hospital-acquired gastrointestinal bleeding outside the critical care unit
-
Qadeer M.A., Richter J.E., Brotman D.J. Hospital-acquired gastrointestinal bleeding outside the critical care unit. J Hosp Med 2006, 1(1):13-20.
-
(2006)
J Hosp Med
, vol.1
, Issue.1
, pp. 13-20
-
-
Qadeer, M.A.1
Richter, J.E.2
Brotman, D.J.3
-
17
-
-
34248205141
-
Intravenous proton pump inhibitor use in hospital practice
-
Slattery E., Theyventhiran R., Cullen G., et al. Intravenous proton pump inhibitor use in hospital practice. Eur J Gastroenterol Hepatol 2007, 19(6):461-464.
-
(2007)
Eur J Gastroenterol Hepatol
, vol.19
, Issue.6
, pp. 461-464
-
-
Slattery, E.1
Theyventhiran, R.2
Cullen, G.3
-
18
-
-
37549020378
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008
-
Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
-
(2008)
Crit Care Med
, vol.36
, Issue.1
, pp. 296-327
-
-
Dellinger, R.P.1
Levy, M.M.2
Carlet, J.M.3
-
20
-
-
0033557191
-
ASHP therapeutic guidelines on stress ulcer prophylaxis
-
American Society of Health-System Pharmacists
-
American Society of Health-System Pharmacists ASHP therapeutic guidelines on stress ulcer prophylaxis. Am J Health Sys Pharm 1999, 56:347-379.
-
(1999)
Am J Health Sys Pharm
, vol.56
, pp. 347-379
-
-
-
21
-
-
2342447376
-
Stress ulcer prophylaxis in the postoperative period
-
Allen M.E., Kopp B.J., Erstad B.L. Stress ulcer prophylaxis in the postoperative period. Am J Health Syst Pharm 2004, 61(6):588-596.
-
(2004)
Am J Health Syst Pharm
, vol.61
, Issue.6
, pp. 588-596
-
-
Allen, M.E.1
Kopp, B.J.2
Erstad, B.L.3
-
22
-
-
0242363121
-
Prevention and treatment of gastrointestinal complications in patients on mechanical ventilation
-
Mutlu G.M., Mutlu E.A., Factor P. Prevention and treatment of gastrointestinal complications in patients on mechanical ventilation. Am J Respir Med 2003, 2(5):395-411.
-
(2003)
Am J Respir Med
, vol.2
, Issue.5
, pp. 395-411
-
-
Mutlu, G.M.1
Mutlu, E.A.2
Factor, P.3
-
23
-
-
4544319097
-
Gastrointestinal complications in patients on mechanical ventilation can be prevented and treated with various drugs
-
Gastrointestinal complications in patients on mechanical ventilation can be prevented and treated with various drugs. Drugs Ther Perspect 2004, 20(9):6-10.
-
(2004)
Drugs Ther Perspect
, vol.20
, Issue.9
, pp. 6-10
-
-
-
24
-
-
0022449888
-
Adverse reactions and interactions with H2-receptor antagonists
-
Penston J., Wormsley K.G. Adverse reactions and interactions with H2-receptor antagonists. Med Toxicol 1986, 1(3):192-216.
-
(1986)
Med Toxicol
, vol.1
, Issue.3
, pp. 192-216
-
-
Penston, J.1
Wormsley, K.G.2
-
25
-
-
0033779366
-
The rates of common adverse events in patients treated with proton pump inhibitors omeprazole, lansoprazole and pantoprazole in general practice in England
-
Martin R.M., Dunn N.R., Freemantle S., et al. The rates of common adverse events in patients treated with proton pump inhibitors omeprazole, lansoprazole and pantoprazole in general practice in England. Br J Clin Pharmacol 2000, 50(4):366-372.
-
(2000)
Br J Clin Pharmacol
, vol.50
, Issue.4
, pp. 366-372
-
-
Martin, R.M.1
Dunn, N.R.2
Freemantle, S.3
-
26
-
-
0036251229
-
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity
-
Zedtwitz-Liebenstein K., Wenisch C., Patruta S., et al. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med 2002, 30(5):1118-1122.
-
(2002)
Crit Care Med
, vol.30
, Issue.5
, pp. 1118-1122
-
-
Zedtwitz-Liebenstein, K.1
Wenisch, C.2
Patruta, S.3
-
27
-
-
0030059570
-
Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis
-
Ben-Menachem T., McCarthy B.D., Fogel R., et al. Prophylaxis for stress-related gastrointestinal hemorrhage: a cost effectiveness analysis. Crit Care Med 1996, 24(2):338-345.
-
(1996)
Crit Care Med
, vol.24
, Issue.2
, pp. 338-345
-
-
Ben-Menachem, T.1
McCarthy, B.D.2
Fogel, R.3
-
28
-
-
0030805907
-
A review of stress ulcer prophylaxis in the neurosurgical intensive care unit
-
Lu W.Y., Rhoney D.H., Boling W.B., et al. A review of stress ulcer prophylaxis in the neurosurgical intensive care unit. Neurosurgery 1997, 41(2):416-426.
-
(1997)
Neurosurgery
, vol.41
, Issue.2
, pp. 416-426
-
-
Lu, W.Y.1
Rhoney, D.H.2
Boling, W.B.3
|